QIAGEN N.V. (QGEN) Stock Analyst Ratings
USA - NYSE:QGEN - NL0015002CX3 - Common Stock
46.33 USD
-0.86 (-1.82%)
46.33 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 74% to QGEN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 52.39. This target is 13.07% above the current price.
QGEN was analyzed by 24 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about QGEN.
In the previous month the buy percentage consensus was at a similar level.
QGEN was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-06-26 | B of A Securities | Maintains | Buy -> Buy |
| 2025-06-24 | Barclays | Initiate | Overweight |
| 2025-04-21 | Baird | Maintains | Neutral -> Neutral |
| 2025-04-04 | Redburn Atlantic | Downgrade | Buy -> Neutral |
| 2025-02-19 | Baird | Downgrade | Outperform -> Neutral |
| 2025-02-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-01-06 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-10-17 | HSBC | Downgrade | Buy -> Hold |
| 2024-08-02 | Baird | Maintains | Outperform -> Outperform |
| 2024-06-27 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2024-06-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-05-01 | Stifel | Maintains | Hold -> Hold |
| 2024-02-16 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2024-02-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-08 | Citigroup | Maintains | Buy -> Buy |
| 2023-12-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-12-19 | Wells Fargo | Initiate | Equal-Weight |
| 2023-12-13 | Wolfe Research | Initiate | Peer Perform |
| 2023-12-07 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2023-11-02 | UBS | Maintains | Neutral -> Neutral |
| 2023-10-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-09-26 | Citigroup | Reiterate | Buy -> Buy |
| 2023-09-12 | Baird | Initiate | Outperform |
| 2023-08-09 | UBS | Maintains | Neutral -> Neutral |
| 2023-02-09 | UBS | Maintains | Neutral |
| 2023-02-09 | Citigroup | Maintains | Buy |
| 2022-11-09 | Citigroup | Maintains | Buy |
| 2021-12-14 | Wells Fargo | Maintains | Equal-Weight |
QIAGEN N.V. / QGEN FAQ
Can you provide the average price target for QIAGEN N.V. stock?
24 analysts have analysed QGEN and the average price target is 52.39 USD. This implies a price increase of 13.07% is expected in the next year compared to the current price of 46.33.
What is the consensus rating for QIAGEN N.V. (QGEN) stock?
The consensus rating for QIAGEN N.V. (QGEN) is 74.1667 / 100 . This indicates that analysts generally have a positive outlook on the stock.